BC
Bicara Therapeutics Inc. Common Stock (BCAX)
NASDAQ·Healthcare·Biotechnology
$22.07
-1.81%
Mkt Cap $1.25B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | — | — | — | -$0.72 | -$0.68 | +5.56% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.55 | -$0.67 | -21.82% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.54 | -$0.50 | +7.41% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.40 | -$0.68 | -70.00% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$0.31 | -$0.39 | -25.81% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.46 | -$1.60 | -247.83% | — | — |
| Q3 2024 Sep 13, 2024 | — | — | — | — | -$0.27 | — | — | — |
| Q2 2024 Jun 30, 2024 | — | — | — | — | -$0.27 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.23 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.42 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.15 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.15 | — | — | — |